Health ProductsDear Healthcare Professional Letter

Acid Concentrate 45X - Urgent Product Recall for Two (2) Lots due to Particulate Matter - For Health Professionals

· Published by Health Canada · Official notice

Details

Alert type: Dear Healthcare Professional Letter
Category: Drugs
Issue: Important Safety Information, Contamination
Audience: Healthcare Professionals
Department: Health Canada
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Details

This is duplicated text of a letter from Baxter Corporation. Contact the company for a copy of any references, attachments or enclosures.

Notice about Health Canada advisories

Health Canada Endorsed Important Safety Information on Acid Concentrate 45X (45 K, 67.5 Ca) and Acid Concentrate 45X (45 K, 45.0 Ca)

September 19, 2014

Dear Health Care Professional,

Subject: Urgent Product Recall for Two (2) Lots of Acid Concentrate 45X (45 K, 67.5 Ca) 4.5L (DIN 02158256) and Acid Concentrate 45X (45 K, 45.0 Ca) 4.5L (DIN 00860611) due to particulate matter

Baxter Corporation in consultation with Health Canada would like to inform you that Baxter has initiated a recall of two (2) lots of concentrated hemodialysis solution, Acid Concentrate 45X (45K, 67.5 Ca) and Acid Concentrate 45X (45K. 45.0Ca), due to particulate matter identified along the solution rim. There is potential for patient injury. These lots were distributed in Canada between January 31, 2014 and July 18, 2014.

  • The identified particulate matter may coat dialyzer fibers making the solute clearance inefficient causing inadequate dialysis, or may pass through the filter and could potentially cause an allergic reaction or an embolic event.
  • Baxter is advising all users to immediately locate and remove the affected lots from use and return all affected inventory to Baxter Corporation. The affected lots should not be used.
  • Healthcare professionals are advised to contact their home hemodialysis patients to notify them of the recall. Patients should be advised not to use recalled product and obtain product from unaffected lots.

Baxter is recalling the following two (2) lots. 

Acid Concentrate 45X (45K, 67.5Ca) Product Code: D12255M Lot No: W4D17D1
Acid Concentrate 45X (45K, 45.0Ca) Product Code: D12188M Lot No: W4A24D1

The specified Acid Concentrate Hemodialysis Solution lots should not be used. Contact Baxter Customer Care to arrange for return and credit of the affected lot numbers at 1-888-719-9955. Baxter is currently investigating this issue and has not received any reports of adverse events for the specified lots.

Acid Concentrate hemodialysis solution is proportioned with Bicarbonate concentrate and purified water to produce dialysate.

Repeated ineffective solute clearance can result in patient symptoms including weakness, tiredness, lack of energy, shortness of breath and mental status changes. Particulate matter passing into the dialysis patient’s blood stream may result in serious patient injury, such as an allergic response, and/or an embolic event.

Managing marketed health product-related adverse reactions depends on health care professionals and consumers reporting them. Reporting rates determined on the basis of spontaneously reported post-marketing adverse reactions are generally presumed to underestimate the risks associated with health product treatments. Any case of serious or unexpected adverse reactions in patients receiving Concentrated Hemodialysis Solutions should be reported to Baxter Corporation or Health Canada.

Baxter Corporation
Mailing address:
Attn: Pharmacovigilance
7125 Mississauga Road
Mississauga, ON
L5N 0C2
Phone: 1-800-387-8399 ext 6607
E-Mail: canada_pharmacovigilance@baxter.com
Fax: 1-855-767-4573

To correct your mailing address or fax number, contact Baxter Customer Care at 1-888-719-9955.

You can report any suspected adverse reactions associated with the use of health products to Health Canada by:

  • Calling toll-free at 1-866-234-2345, or
     
  • Visiting MedEffect Canada's Web page on Adverse Reaction Reporting for information on how to report online, by mail or by fax.

For other health product inquiries related to this communication, contact Health Canada at:
Health Products and Food Branch Inspectorate
E-mail: DCVIU_UVCEM@hc-sc.gc.ca
Telephone: 1-800-267-9675
Fax: 613-946-5636

Sincerely,

original signed by

Danielle Tokarski
Quality Systems Manager
Baxter Corporation

For more information

The manufacturer advised Health Canada of the risk associated with this health product's quality. Health Canada supports the actions taken by the manufacturer and as such a risk assessment was not required and a Summary Safety Review was not prepared.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime